You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

NADOLOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Nadolol patents expire, and when can generic versions of Nadolol launch?

Nadolol is a drug marketed by Alembic, Amneal Pharms Co, Aurobindo Pharma, Beximco Pharms Usa, Chartwell Rx, Heritage Pharma, Invagen Pharms, Novast Labs, Rising, Rk Pharma, Sandoz, Teva Pharms, Zydus Pharms, Impax Labs, and Natco Pharma. and is included in sixteen NDAs.

The generic ingredient in NADOLOL is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NADOLOL?
  • What are the global sales for NADOLOL?
  • What is Average Wholesale Price for NADOLOL?
Drug patent expirations by year for NADOLOL
Drug Prices for NADOLOL

See drug prices for NADOLOL

Drug Sales Revenue Trends for NADOLOL

See drug sales revenues for NADOLOL

Recent Clinical Trials for NADOLOL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Unity Health TorontoN/A
National Institute on Aging (NIA)Phase 4
The New York Community TrustPhase 4

See all NADOLOL clinical trials

Pharmacology for NADOLOL
Medical Subject Heading (MeSH) Categories for NADOLOL

US Patents and Regulatory Information for NADOLOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms NADOLOL nadolol TABLET;ORAL 207761-003 Jul 28, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rk Pharma NADOLOL nadolol TABLET;ORAL 212856-003 Sep 13, 2019 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco Pharma NADOLOL AND BENDROFLUMETHIAZIDE bendroflumethiazide; nadolol TABLET;ORAL 078688-002 Feb 15, 2008 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising NADOLOL nadolol TABLET;ORAL 074172-002 Oct 31, 1993 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz NADOLOL nadolol TABLET;ORAL 074501-001 Nov 9, 1995 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.